What are the bases for producing plans for tuberculosis (TB) preventive medicine demand procured via Health Insurance Fund (HIF) at medical establishments in Vietnam?

Pursuant to Article 8 of the Circular 36/2021/TT-BYT (takes effect from 15/02/2022) stipulating the bases for producing plans for TB preventive medicine demand procured via HIF at medical establishments in Vietnam as follows:

The plans for TB preventive medicine demand procured via HIF at medical establishments shall be produced based on any of the following information:

- Estimated number of people suspected with TB, having TB, having drug-resistant TB, having latent TB and receiving treatment by December 31 inclusive of the year preceding the planning year and estimated number of people having TB in the planning year.

- Estimated quantity of TB preventive medicine in store for each treatment regimen at the medical establishments by December 31 inclusive of the year preceding the planning year. Quantity of TB preventive medicine in store at medical establishments at the end of the year, transferred to the following year, and deducted from procurement plan of the following year. Procurement, use, and storage of TB preventive medicine procured using other funding sources in the year preceding the planning year.

- TB treatment regimen built based on applicable TB diagnosis, treatment, and prevention guidelines.

- List of TB preventive medicine under Appendix 1 attached to Circular No. 30/2018/TT-BYT dated October 30, 2018 of Minister of Health and List of medicine used in Projects for prevention of some diseases dangerous to public health (Tuberculosis) under Section III Part C of Appendix II attached to Circular No. 15/2020/TT-BYT dated August 10, 2020 of Minister of Health.

- Guidelines on producing plans for TB preventive medicine demand procured via HIF, orientation for converting treatment regimen of national contact points.

Best regards!